precision dosing

Attune Biotech is the operating name of Biostax Corp, a late clinical-stage biopharmaceutical company developing Lodonal™ and JKB-122, proprietary naltrexone-based therapies built on precision dosing and modified-release formulation science. The company is developing a host-directed immune restoration platform targeting shared upstream immune and inflammatory processes across neuroimmune, inflammatory, infectious disease, and metabolic applications.

clinical trialsCMC packagemanufacturing controlsmodified-release formulation

Dank Blossom Inc. specializes in helping veterans and those with chronic medical conditions navigate home cultivation and medical application of cannabis. It provides standardized protocols for plant anatomy, organic growing techniques, and precision dosing, along with guidance on legal and safety compliance, terpene profiling, and milligram intake calculation. It also offers custom medicinal-grade home-grow systems and an integrated AI Assistant and Grow Journal for tracking and troubleshooting.

compliance and risk mitigation guidancecustom home-grow system designhome cultivation guidanceorganic growing techniquesterpene profiling

Fudo Labs is building a platform of next-generation technology solutions for vertical farming, aiming to make controlled-environment technologies accessible and economically competitive with traditional farming. Its devices are developed to optimize resource consumption, simplify ease of use, and minimize operating costs.

climate controlIoT integrationIoT systems designmodular vertical farm deploymentwater-cooled lighting

Hikari Medical Technologies is developing NAGOMI™, a noninvasive precision dosing platform combining light-enabled drug release and real-time monitoring for safer, more controllable therapies. The platform integrates monitorable carriers, a light-enabled wearable, and optical feedback in one therapeutic interface. The company has preclinical programs in hepatorenal syndrome, pulmonary hypertension, multiple myeloma, and Parkinson's disease, and collaborates with pharma, government innovation programs, and translational labs.

light-enabled drug releaseoptical feedbackreal-time monitoring